Clinical Trial Update: Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium [Phase 3]

View source ↗

Summary

Phase 3 trial update exploring minocycline to attenuate postoperative cognitive dysfunction and delirium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of the Rectum
• Colon Cancer
• Prostate Cancer
• Renal Cancer

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: RenJi Hospital | Conditions: Prostate Cancer, Carcinoma of the Rectum | Phase 3 | Status: UNKNOWN